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Hepatitis C virus (HCV) NS5A is a phosphoprotein that possesses a cryptic trans-activation activity. To investigate its
potential role in viral replication, we searched for the cellular proteins interacting with NS5A protein by yeast two-hybrid
screening of a human hepatocyte cDNA library. We identified a newly discovered soluble N-ethylmaleimide-sensitive factor
attachment protein receptor-like protein termed human vesicle-associated membrane protein-associated protein of 33 kDa
(hVAP-33). In vitro binding assay and in vivo coimmunoprecipitation studies confirmed the interaction between hVAP-33 and
NS5A. Interestingly, hVAP-33 was also shown to interact with NS5B, the viral RNA-dependent RNA polymerase. NS5A and
NS5B bind to different domains of hVAP-33: NS5A binds to the C-terminus, whereas NS5B binds to the N-terminus of
hVAP-33. Immunofluorescent staining showed a significant colocalization of hVAP-33 with both NS5A and NS5B proteins.
hVAP-33 contains a coiled-coil domain followed by a membrane-spanning domain at its C-terminus. Cell fractionation analysis
revealed that hVAP-33 is predominantly associated with the ER, the Golgi complex, and the prelysosomal membrane,
consistent with its potential role in intracellular membrane trafficking. These interactions provide a mechanism for membrane
association of the HCV RNA replication complex and further suggest that NS5A is a part of the viral RNA replication complex.
© 1999 Academic Press
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Hepatitis C virus (HCV), a member of the Flaviviridae
amily, is a positive-sense, single-stranded RNA virus,
hich has been shown to be the major causative
gent of non-A, non-B hepatitis (Kuo et al., 1989; Aach
t al., 1991; Choo et al., 1991). The 9.5-kb viral genome
ncodes a single polyprotein of about 3010 amino
cids, which is proteolytically processed by a combi-
ation of host- and virus-encoded proteases into at
east 10 distinct products in the order of NH2-C-E1-E2-
7-NS3-NS4A-NS4B-NS5A-NS5B-COOH (Grakoui et
l., 1993; Lohmann et al., 1996). Among the nonstruc-
ural proteins (NS2–5B), NS3 is a serine protease and
lso exhibits NTPase (Suzich et al., 1993) and RNA
elicase activities (Tai et al., 1996), suggesting its
otential role in viral RNA synthesis. NS5B contains a
GDD” sequence motif, which is highly conserved
mong all RNA-dependent RNA polymerases (RdRps)
Poch et al., 1989). RdRp activities of recombinant
1 To whom correspondence and reprint requests should be ad-
ressed at Howard Hughes Medical Institute, Department of Molecular
icrobiology and Immunology, University of Southern California School
f Medicine, 2011 Zonal Avenue, HMR-401, Los Angeles, CA 90033-
v054.
042-6822/99 $30.00
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30S5B proteins purified from transfected insect cells
Behrens et al., 1996) and a bacterial expression sys-
em (Yamashita et al., 1998) have been reported. Based
n their enzymatic activities, NS3 and NS5B are pre-
umed to be involved in viral RNA replication. The
unction of NS5A is not yet clear; it is a phosphoprotein
Tanji et al., 1995) and contains a putative nuclear
ocalization signal that can target a heterologous re-
orter gene product to the nucleus, although the native
S5A is retained in the cytoplasm (Ide et al., 1996).
he N-terminus-truncated, but not the full-length,
S5A is a potent transcriptional activator (Kato et al.,
997). Whether this trans-activation activity is related
o HCV RNA synthesis is not clear. NS5A contains an
nterferon-sensitivity-determining region (ISDR) in the
entral part of the protein (Enomoto et al., 1996;
oshiko et al., 1998). It can interact with the
nterferon-inducible double-stranded-RNA-dependent
rotein kinase (PKR) and function as a repressor of
KR (Gale et al., 1997). This is believed to be one of the
echanisms of HCV-mediated interferon (IFN) resis-
ance. Most of the viral nonstructural proteins have
een shown to be associated with the cellular mem-
rane structures (Hijikata et al., 1993), probably form-
ng a complex to perform critical functions during the
iral replication cycle. A number of these proteins, i.e.,
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31INTERACTION OF HCV NS5A AND NS5B WITH A SNARE-LIKE PROTEIN7, NS4A, NS4B, and NS5B, contain conserved hydro-
hobic stretches that may anchor this complex to
embranes. The membrane retention ability of these
ydrophobic sequences has been confirmed only for
S5B (Yamashita et al., 1998), and the mechanism for
embrane association of the replication complex is
till not clear.
RNA replication of most RNA viruses involves cer-
ain intracellular membrane structures, including the
R (Restrepo-Hartwig and Ahlquist, 1996; Schaad et
l., 1997; van der Meer et al., 1998), Golgi (Shi et al.,
999), endosomes and lysosomes (Froshauer et al.,
988), or a membrane structure derived from several
embrane compartments (Bienz et al., 1992). RNA
ynthesis of other flaviviruses, such as Dengue virus
Cauchi et al., 1991) and West Nile virus (Wengler et al.,
990), has also been shown to occur principally on the
embrane of the ER. Similarly, some of the presumed
CV replicase components, NS3 and NS5B, sediment
ith membrane fractions isolated from transfected
ells (Hijikata et al., 1993; Hwang et al., 1997). Thus, it
ppears that membrane association of the viral repli-
ation complex is essential for viral RNA replication.
owever, the mechanism by which the viral replication
omplex is associated with selected membrane com-
onents is largely unknown.
The current model for vesicle docking and fusion at all
ocations, including synapses, involves SNARE proteins
Sollner et al., 1993; Goda, 1997; Woodman, 1997). This
niversal vesicle transport machinery consists of an N-
thylmaleimide-sensitive fusion protein (NSF), soluble
SF attachment proteins (SNAPs), and two types of
NAP receptors (SNAREs), namely v-SNAREs and
-SNAREs. Vesicle docking is achieved by the interaction
etween v-SNAREs on the vesicle membrane and the
-SNAREs on the target membrane. Vesicle-associated
embrane protein (VAMP), which is more often known
s synaptobrevin, is one of the v-SNAREs (Trimble et al.,
988; Baumert et al., 1989; Schiavo et al., 1995). The
NARE proteins have been found in many species and
re distributed in a broad range of tissues and mem-
rane compartments of the cell (Aalto et al., 1993; Ban-
ield et al., 1994; Becherer et al., 1996; Nichols et al., 1997;
dvani et al., 1998), suggesting that they may play a
undamental role in vesicle biogenesis, protein sorting,
nd membrane fusion.
In this study, we screened an interferon-induced
uman hepatocyte cDNA library using HCV NS5A as
ait and isolated a SNARE protein named human
AMP-associated protein of 33 kDa (hVAP-33) (Weir et
l., 1998). hVAP-33 can also bind to the NS5B protein,
uggesting that hVAP-33 may be responsible for the
ssociation of the HCV replication complexes with the
embrane. cRESULTS
dentification of a human cellular protein interacting
ith HCV NS5A protein
Since the role of NS5A in the HCV life cycle is not
nown, we sought to understand its potential function by
tudying its cellular partners. Therefore, we performed a
east two-hybrid screening using the full-length NS5A of
CV genotype 1a as bait to identify cellular proteins that
an potentially interact with HCV NS5A protein. We
creened a cDNA library derived from HepG2 cells that
ad been treated with interferon, since previous studies
howed that NS5A may potentially confer interferon re-
istance (Enomoto et al., 1996; Gale et al., 1997; Toshiko
t al., 1998). Of 2.8 3 106 transformants screened, seven
ositive clones, which contain cDNAs encoding NS5A-
nteracting proteins, were obtained. DNA sequence anal-
sis revealed that two of the seven positive clones, 42
nd 74, contained identical sequences within the open
eading frames, although they differed in the length of
heir noncoding sequences. The other five cDNAs iso-
ated during this screening will be described elsewhere.
A BLAST search against the GenBank database
howed that this NS5A-binding protein has a sequence
dentical to that of hVAP-33, which is the human homolog
f the Aplysia californica VAP-33 (Weir et al., 1998).
AP-33 has been shown to be one of the SNAREs re-
uired for A. californica neurotransmitter release (Skehel
t al., 1995). The hVAP-33 protein contains 242 amino
cids (aa) and shares 49% aa identity with A. californica
AP-33. Based on the predictions by computer analysis,
he N-terminal 130 aa residues of the protein form a
onserved domain that belongs to the IgG-like superfam-
ly (Bullock et al., 1996) (Fig. 1a). The region from aa 162
o 198 is predicted to be a leucine zipper able to form a
arallel double-stranded coiled-coil structure, which is
onsidered to be important for protein–protein interac-
ions among the SNAREs (Canaves and Montal, 1998). It
s noteworthy that another NS5A-binding protein identi-
ied during the same screening also harbors a leucine
ipper motif within the binding domain (Tu and Lai, un-
ublished observations). The region from aa 221 to 239
as a highly hydrophobic sequence and is predicted to
pan the cellular membrane (Fig. 1a). The homology
etween the N-terminal regions (65%) of the A. califor-
ica VAP-33 and hVAP-33 is much higher than that be-
ween their C-terminal regions (35%). The hydrophobicity
nalysis (Fig. 1b) revealed that the hydrophobic and
ydrophilic regions are conserved between the two spe-
ies. hVAP-33 has a predicted molecular mass of 27.3
Da. The apparent molecular mass was determined to
e approximately 30 kDa when translated in vitro (data
ot shown) and by Western blotting of the endogenous
VAP-33 in HepG2 cells with a rat polyclonal antibody
ade against a recombinant hVAP-33 from Escherichiaoli.
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32 TU ET AL.VAP-33 interacts with both NS5A and NS5B in vitro
To confirm that hVAP-33 can interact with HCV NS5A
irectly in vitro, we first used a glutathione S-transferase
GST) pull-down assay. E. coli-expressed GST–hVAP-33
usion protein was purified with glutathione–Sepharose
B beads. In vitro translated 35S-labeled NS5A was incu-
ated with GST–hVAP-33 fusion protein to assay for bind-
ng. The result showed that NS5A was able to bind
ST–hVAP-33 (Fig. 2A, lane 3) under the in vitro binding
onditions. We also tested other HCV proteins, including
ore and NS4B. None of these proteins bound to GST–
VAP-33 (data not shown). Surprisingly, however, NS5B
nteracted with GST–hVAP-33 with at least the same
inding intensity as did NS5A (Fig. 2A, lane 4). In con-
rast, neither NS5A nor NS5B bound GST protein under
he same conditions (lane 6). These data indicate that
S5A and NS5B specifically interact with hVAP-33. Fur-
hermore, the binding of NS5B did not interfere with the
inding of NS5A or vice versa (lane 5). These results
uggest that NS5A and NS5B may interact with two
ifferent domains of hVAP-33.
To map the HCV NS5A- and NS5B-interacting domains
f hVAP-33, three truncated constructs of hVAP-33 (Fig.
B), expressed as GST-fusion proteins, were incubated
ith in vitro translated 35S-labeled NS5A or NS5B. The
esults indicate that NS5A bound primarily to the C-
erminal region (aa 156–242), which contains the coiled-
oil sequence (Fig. 2B, lane 5). The N-terminal 75 or 155
a of hVAP-33 bound NS5A only very weakly (lanes 3 and
). In contrast, NS5B primarily bound the N-terminal 75 or
55 aa of hVAP-33 (lanes 9 and 10). The C-terminal
ragment (aa 156–242) bound NS5B only very weakly
lane 11). These results indicate that the C-terminal one-
hird of hVAP-33 contains the critical residues for binding
S5A, whereas its N-terminal 75 aa are essential for
FIG. 1. Characteristics of hVAP-33 protein. (A) Structural domains of t
f the protein form a conserved domain that belongs to the IgG-like sup
he region of aa 221–239 has a highly hydrophobic sequence to form a
acVector program.S5B interaction. These data established that NS5A and oS5B bound to different regions of hVAP-33, suggesting
hat both NS5A and NS5B could simultaneously and
ndependently interact with hVAP-33.
VAP-33 interacts with NS5A and NS5B in vivo
To demonstrate the potential interaction of hVAP-33
ith both NS5A and NS5B in the cells, we performed a
oimmunoprecipitation experiment from the cells ex-
ressing both NS5A and NS5B. For this purpose, Flag-
agged hVAP-33 was coexpressed with NS5A or NS5B in
OS7 cells using T7 expression plasmids coupled with
ecombinant vaccinia virus (vTF7-3) infection expressing
7 polymerase. Cell lysates were immunoprecipitated
ith anti-Flag antibody-crosslinked Sepharose 4B beads.
he immunoprecipitates were analyzed by SDS–PAGE
ollowed by immunoblotting with a rabbit polyclonal anti-
S5A and HCV patient serum to detect NS5A and NS5B,
espectively. The results showed that NS5A was co-
mmunoprecipitated with hVAP-33 (Fig. 3, lane 3),
hereas NS5A alone could not be precipitated by the
nti-Flag antibody (lane 2). Similarly, NS5B was specifi-
ally coprecipitated with hVAP-33 (lanes 4 to 6). Further-
ore, when both NS5A and NS5B were coexpressed
ith N-Flag hVAP-33, they were coprecipitated almost
qually efficiently (lanes 7 to 9). These results indicate
hat NS5A and NS5B bound specifically to hVAP-33 in the
ells and that these two proteins bound independently to
VAP-33 at equimolar ratio.
olocalization of NS5A and NS5B with the
ndogenous hVAP-33
The results shown above indicate that NS5A and
S5B can interact with the overexpressed hVAP-33 in
itro and in vivo. To determine the biological significance
P-33 protein based on computer analysis. N-terminal 130 aa residues
y. The region of aa 162–198 is predicted to form a coiled-coil structure.
embrane domain. (B) Hydrophilicity plots of hVAP-33 obtained by thehe hVA
erfamil
transmf these interactions, we further studied whether these
v
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33INTERACTION OF HCV NS5A AND NS5B WITH A SNARE-LIKE PROTEINiral proteins colocalized with the endogenous hVAP-33.
e first investigated the subcellular localization of the
ndogenous hVAP-33 by indirect immunofluorescent
FIG. 2. In vitro interaction of hVAP-33 with NS5A and NS5B. (A) GST
nd precipitated by glutathione beads. GST protein alone was used as a
n lanes 3 to 6. (B) Mapping the NS5A- and NS5B-binding domains on h
roteins and incubated with in vitro translated 35S-labeled NS5A and
chematic drawing.nalysis in COS7 cells. The endogenous hVAP-33 was ietected by rat polyclonal antibody generated against
he bacteria-expressed hVAP-33. Immunofluorescent
taining of the hVAP-33 protein showed that it was local-
3 was incubated with in vitro translated 35S-labeled NS5A and NS5B
ive control (lane 6). Lanes 1 and 2 represent 10% of input proteins used
. Various truncated hVAP-33 constructs were expressed as GST-fusion
he binding sites on hVAP-33 for NS5A and NS5B are indicated by a-hVAP-3
negat
VAP-33
NS5B. Tzed exclusively in the cytoplasm (Fig. 4). Double staining
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34 TU ET AL.f hVAP-33 protein and a marker for the ER (GRP78)
evealed partial colocalization of these proteins (data not
hown), suggesting that at least some of the hVAP-33
rotein is associated with the ER. There was no detect-
ble staining when preimmune rat serum was used (data
ot shown). To compare the subcellular localization of
VAP-33 with NS5A and NS5B, we transfected COS7
ells with either pcDNA3/NS5A or pcDNA3.1/Flag-NS5B.
mmunofluorescent staining was performed using rabbit
olyclonal anti-NS5A and an anti-Flag antibody to detect
S5A and NS5B, respectively. Confocal microscopy
howed a significant colocalization of the endogenous
VAP-33 with NS5A and NS5B (Fig. 4, top two rows).
urthermore, using a COS7 cell line stably expressing
S5A, we also found a similar colocalization of NS5A
ith hVAP-33 (data not shown). Finally, when cells were
otransfected with plasmids expressing both NS5A and
S5B, the two proteins also colocalized (Fig. 4, bottom
ow). These results indicate that NS5A and NS5B colo-
alized with the endogenous hVAP-33.
ubcellular localization of hVAP-33 by cell
ractionation
The colocalization of NS5A and NS5B with hVAP-33
uggests that the HCV replication complex is associated
ith the membrane where hVAP-33 is localized. There-
ore, it is of interest to fine-map the membrane localiza-
ion of hVAP-33. For this purpose, we fractionated cellular
embranes by a two-dimensional fractionation proce-
ure with sorbital density gradient sedimentation on the
irst dimension, followed by phase partitioning at pH
.0–6.6 shift on the second dimension (Gierow et al.,
996; Mircheff, 1996; Hamm-Alvarez et al., 1997). For
echnical reasons, we initially used rabbit lacrimal gland
FIG. 3. In vivo coimmunoprecipitation of hVAP-33 with NS5A and NS
OS7 cells. Cell lysates were immunoprecipitated with anti-Flag-cross
sed to detect NS5A and NS5B, respectively. COS7 cells transfected wi
anes 1, 4, and 7 represent 10% of lysates prior to immunoprecipitatiocinar cells, which have active secretory activities, for che subcellular localization of hVAP-33. The separation of
ellular membranes was monitored by enzyme markers
ssociated with the different membranes, while VAP-33
as detected by Western blotting with the rat polyclonal
ntibody. This procedure produced clear separation of
ost subcellular organelles, except that the ER and the
olgi overlapped considerably at pH 7.0–6.6 shift (Fig. 5,
ottom). We also performed the phase partitioning at pH
.6, which better separated the ER from the Golgi appa-
atus; however, the separation of other organelles was
ot as good as that at pH 7.0–6.6 shift (data not shown).
combination of the results generated under two differ-
nt pH conditions allowed us to conclude that VAP-33 is
resent predominantly in the ER and Golgi apparatus,
ith some in the trans-Golgi network and prelysosomes
Fig. 5). Very little was detected on the plasma mem-
rane, the lysosomes, or the endosomes (Fig. 5). Prelim-
nary analysis also showed that hVAP-33 and NS5A have
similar subcellular distribution pattern in HepG2 cells
data not shown).
DISCUSSION
Considerable evidence suggests that most of the HCV
onstructural proteins, including NS3 and NS5B, which
re presumably involved in viral RNA synthesis, are as-
ociated with host cell membranes (Hijikata et al., 1993).
hus, HCV replication most likely occurs in close asso-
iation with the cellular membrane (Hijikata et al., 1993),
hich is a characteristic feature shared by most positive-
ense RNA viruses (Grun and Brinton, 1988; Wengler et
l., 1990; Cauchi et al., 1991; Bienz et al., 1992; Schaad et
l., 1997; van der Meer et al., 1998; Shi et al., 1999).
owever, the RNA replication complexes of different
iruses appear to be associated with different membrane
g-tagged hVAP-33 was cotransfected with NS5A or NS5B or both into
Sepharose 4B beads. Rabbit anti-NS5A and HCV patient serum were
or NS5B alone (lanes 2, 5, and 8) were used as the negative controls.5B. Fla
linked
th NS5Aompartments; the mechanism underlying the direction
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35INTERACTION OF HCV NS5A AND NS5B WITH A SNARE-LIKE PROTEINf viral replication complexes to different cellular mem-
ranes is largely unknown. In the case of a plant RNA
irus, tobacco etch virus, it has been shown that a virus-
ncoded protein containing hydrophobic domains tar-
ets the replication complex to the membrane derived
rom the ER, forming a membrane-bound scaffold for the
iral replication–transcription complexes (Schaad et al.,
997). In this study, we report the isolation of a SNARE-
ike membrane protein, hVAP-33, by yeast two-hybrid
creening in human hepatocytes using NS5A as bait. Our
ata showed that, in addition to NS5A, NS5B (RNA poly-
erase) is complexed with hVAP-33 both in vitro and in
ivo, suggesting that hVAP-33 may serve as a membrane
eceptor for HCV replication complexes.
The C-terminal 21 aa residues of NS5B, including an
nchoring domain and a C-terminal tail, has been shown
o play a role in anchoring the protein to the membrane
Yamashita et al., 1998). However, it is not known whether
t targets the protein to any specific membrane site. Our
indings here provide a mechanism for the association of
he RNA replication complex with specific cellular mem-
FIG. 4. Colocalization of NS5A, NS5B, and endogenous hVAP-33
mmunofluorescent staining was performed using a rat polyclonal an
nti-Flag antibody to detect hVAP-33, NS5A, and NS5B, respectively.ranes, that is, through binding to a specific cellularembrane protein, hVAP-33. However, this conclusion
oes not rule out the possibility that the viral proteins
ay also directly interact with membrane or other cellu-
ar membrane proteins. In fact, it is likely that HCV pro-
eins engage in multiple protein–protein interactions.
VAP-33 is predicted to be a transmembrane protein with
membrane-spanning domain very close to the C-termi-
us of the protein. Although hVAP-33 has not been ex-
ensively characterized, it is likely that it has a membrane
rientation similar to that of the SNARE proteins, inas-
uch as the hVAP-33 preserves all of the hydrophobicity
haracteristics of the A. californica VAP-33, which has
een shown to have the vesicle transport function of the
NARE proteins (Skehel et al., 1995). Thus, the majority
f the hVAP-33 protein is likely present on the cytoplas-
ic side of the intracellular membrane compartments.
his extensive cytoplasmic “arm” of hVAP-33 provides an
deal membrane-docking site for the NS5A and NS5B
roteins (Fig. 2B). Additional viral or cellular proteins may
lso be recruited by interacting with one or more of these
roteins to form a functional HCV replication complex.
or Flag-tagged NS5B or both were transfected into COS7 cells.
against hVAP-33, a rabbit polyclonal antibody against NS5A, and the. NS5A
tibodyThe function of NS5A is so far unknown. Our finding
t
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36 TU ET AL.hat NS5A, together with NS5B, is associated with
VAP-33 suggests that NS5A is also involved in HCV
FIG. 5. Two-dimensional fractionation analysis of VAP-33. The deta
amm-Alvarez et al., 1997). Female rabbit lacrimal gland acinar cell ly
ractions were pooled (1–2, 3–6, 7–8, 9–10, 11–12, 13) and then subjec
arkers in each fraction was performed as described previously (Mirch
y Western blotting using a rat polyclonal antibody. ER, endoplasmic
embrane-related endosome; LYS, lysosome; pre-LYS, prelysosome;
etwork; SV, secretory vesicle; P, pellete. The circles outlined by thickNA replication by direct or indirect interaction with tS5B. Interestingly, NS5A and NS5B bind to separate
omains of hVAP-33; thus NS5A can be associated with
ethod was described previously (Gierow et al., 1996; Mircheff, 1996;
ere first separated into 13 fractions on a 26.5–80% sorbitol gradient.
phase partitioning at pH 7.0–6.6 shift. Biochemical analysis of enzyme
9; Gierow et al., 1996; Hamm-Alvarez et al., 1997). VAP-33 was detected
um; GOL, Golgi; BLM, basal-lateral membrane; BLMRE, basal-lateral
, high-density trans-Golgi network; LD-TGN, low-density trans-Golgi
dicate the approximate fractions that contain the VAP-33 protein.iled m
sates w
ted to
eff, 198
reticulhe membrane independently of NS5B. NS5A is a phos-
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37INTERACTION OF HCV NS5A AND NS5B WITH A SNARE-LIKE PROTEINhoprotein (Tanji et al., 1995) and has a trans-activation
ctivity (Kato et al., 1997); these properties may enable
S5A to participate in viral RNA synthesis. This putative
ole of NS5A will need to be confirmed in an HCV RNA
eplication system in mammalian cells. Unfortunately,
uch a system is currently unavailable.
Our finding thus suggests that the HCV RNA replica-
ion complex is likely associated with cellular mem-
ranes, similar to many other viruses. RNA synthesis of
any RNA viruses has been reported to involve the ER,
olgi, endosomes, or lysosomes. For example, the rep-
ication complexes of equine arteritis virus (van der Meer
t al., 1998), brome mosaic virus (Restrepo-Hartwig and
hlquist, 1996), and tobacco etch virus (Schaad et al.,
997) are associated with the ER. Viral RNA synthesis of
urine hepatitis virus has been detected on the Golgi
pparatus in human cells (Shi et al., 1999). Alphavirus
NA replicase has been located to the cytoplasmic sur-
ace of endosomes and lysosomes (Froshauer et al.,
988). More remarkably, the replication of poliovirus RNA
as been shown to occur on a unique membrane com-
artment derived from membranes of the ER, Golgi, and
ther cellular membranes (Bienz et al., 1992). Among
laviviruses, the functional replication complexes of var-
ous viruses have been obtained from membrane frac-
ions (Grun and Brinton, 1988), and flaviviral RNA synthe-
is appears to occur principally on the membrane of the
R (Wengler et al., 1990; Cauchi et al., 1991). Further-
ore, HCV proteins, including the presumed replicase
omponents NS3 and NS5B, sediment with membrane
ractions isolated from transfected cells (Hijikata et al.,
993). Whether NS3 is associated with the membrane
hrough hVAP-33 or indirectly through binding to NS5B
ill be an interesting question.
hVAP-33 is a membrane protein ubiquitously ex-
ressed in mammalian cells (Weir et al., 1998), which
hares 49% identity with the A. californica VAP-33 at the
mino acid level. The A. californica VAP-33 is a plasma
embrane protein of neuron cells (Schiavo et al., 1995).
y direct interaction with VAMP, which is an integral
rotein present in the membrane of vesicles, VAP-33
unctions in the exocytosis of synaptic vesicles. hVAP-33
nd the A. californica VAP-33 share a typical SNARE
tructure, i.e., a coiled-coil structure followed by a mem-
rane-spanning domain at their C-terminal regions. How-
ver, VAP-33 mRNA was detected exclusively in the cen-
ral nervous system of A. californica while hVAP-33
RNA showed a wide range of tissue distribution, based
n our Northern blotting results (data not shown) and the
revious observation by Weir et al. (1998). The clear
ifference in the expression patterns of VAP-33 of differ-
nt species may be related to the obvious difference in
he complexity between human and Aplysia. Alterna-
ively, if this protein family is multigenic, these two
AP-33 proteins may not be orthologous proteins playing
n identical role in the two organisms. hVAP-33 has all of che attributes of a characteristic SNARE protein, although
ts precise functions have not been reported. Thus, it is
ikely that hVAP-33 may participate in diverse vesicle
rafficking between membrane compartments of the cell,
ncluding endocytotic, exocytotic, ER–Golgi, and intra-
olgi transport pathways. Our finding that hVAP-33 is
redominantly in the ER and the Golgi apparatus sug-
ests that it may be involved in vesicle transport between
he ER and the Golgi. hVAP-33 is also present in small
mounts on the trans-Golgi network and prelysosomes.
t may be speculated that the interaction of NS5A and
S5B with hVAP-33 may affect the vesicle transport func-
ions of the host cells.
MATERIALS AND METHODS
lasmid construction
To construct the plasmids used in the yeast two-hybrid
creening, vector pGBT9, which encodes the GAL4 DNA-
inding domain (GAL4 BD), and vector pGAD10, which
ncodes the GAL4 activation domain (GAL4 AD), were
mployed (Clontech, Palo Alto, CA). The HCV NS5A (ge-
otype 1a) was amplified by PCR from a full-length HCV
DNA (Choo et al., 1991) and cloned into GBT9 at EcoRI
nd SalI sites to generate the pGBT9/NS5A construct,
hich can express the GAL4 BD–NS5A fusion protein in
east. The cDNA library was custom-made by Clontech
sing mRNAs from HepG2 cells that had been treated
ith 1000 u/ml of interferon a (Sigma, St. Louis, MO) at
7°C for 20 h. The cDNA was cloned into the EcoRI site
f pGAD10 vector to generate GAL4 AD–cDNA fusion
roteins.
The plasmid used for expressing GST–hVAP-33 fusion
rotein in E. coli was constructed by inserting the
VAP-33 cDNA fragment into the BamHI and EcoRI sites
f the pGEX-4T-1 vector (Novagen, Madison, WI). The
lasmid used to express HCV NS5A protein in COS7
ells was constructed by inserting the PCR-generated
S5A cDNA fragment into KpnI and XbalI sites of
cDNA3 vector (Invitrogen, Carlsbad, CA). Similarly,
S5B sequence derived from the same HCV cDNA as
hat used for NS5A was cloned into the NheI and BamHI
ites of pcDNA3.1 (Invitrogen). These constructs, which
ontain a T7 promoter as well as a cytomegalovirus
mmediate early promoter, were also used for the in vitro
ranslation of NS5A and NS5B proteins.
To construct the mammalian expression vector for
VAP-33 tagged with a Flag epitope, the PCR-generated
VAP-33 fragment containing Flag sequence (GAT TAC
AG GAT GAC GAC GAT AAG) at its 59-end was first
loned into a TA cloning vector (Invitrogen) and then
ubcloned into the BamHI and EcoRI sites of pcDNA3.1.
east two-hybrid screening
Yeast two-hybrid screening was performed with Sac-
haromyces cerevisiae Y190 according to the manufac-
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38 TU ET AL.urer’s instructions (Clontech). Yeast cells were first
ransformed with pGBT9/NS5A plasmid and then se-
uentially transformed with 100 mg of pGAD10/cDNA
sing the lithium acetate method. Double transformants
ere selected on Trp-/Leu-/His- glucose plates supple-
ented with 25 mM 3-amintriazole. Seven days after
ransformation, the surviving cells were tested for b-ga-
actosidase (b-Gal) activity using a filter lift assay. After
eing frozen in liquid nitrogen and thawed at room tem-
erature, filter replicas of yeast transformants were over-
aid on Waterman 3 MM paper saturated with 6-bromo-
-chloro-3-indolyl-b-D-galacosidase solution (0.033% in Z
uffer) and incubated at 30°C for 8 h. Blue colonies were
solated, plated, and tested again for b-Gal activity. Yeast
lones containing only pGAD10/cDNA plasmid were iso-
ated from the positive clones as a result of the sponta-
eous loss of pGBT9/NS5A plasmid in the Trp2 SD me-
ium. The isolated pGAD10/cDNA plasmids were veri-
ied by cotransformation with either pGBT9/NS5A or the
arental plasmid pGBT9. Only those pGAD10/cDNA
lones that develop blue color when cotransformed with
GBT9/NS5A, but not with pGBT9 vector, were consid-
red true positives.
equence analysis
The positive pGAD10/cDNA clones were sequenced
sing a Thermo Sequenase Radiolabeled Terminator Cy-
le Sequencing Kit (Amersham, Piscataway, NJ). The
NA sequences were translated and compared with
onredundant sequence database using a family of
LAST programs (Altschul et al., 1997) through the Na-
ional Center for Biotechnology Information network ser-
ice. Statistically significant matches were analyzed with
he CLUSTAL_X program (Thompson et al., 1997), pro-
ucing multiple sequence alignments, or the PCGENE
rogram. The resulting alignments were sent as input for
he PHD program to predict secondary structure (Rost,
996) and transmembrane (Rost et al., 1996) and coiled-
oil (Lupas et al., 1991) regions. Hydrophobicity profiles
ere obtained by the MacVector program.
ST pull-down assay
pGEX-4T-1 or pGEX-4T-1/hVAP-33 plasmids were
ransformed and expressed in E. coli BL21 (DE3) (Nova-
en). GST or GST-fusion proteins were purified with glu-
athione–Sepharose 4B beads. The amounts of purified
roteins were estimated by Coomassie blue staining of
DS–polyacrylamide gels. 35S-labeled NS5A protein was
n vitro translated in the TNT T7 Quick Coupled Tran-
cription/Translation System (Promega, Madison, WI) us-
ng pcDNA3/NS5A and pcDNA3.1/NS5B plasmid DNA as
emplates. Equal amounts of GST and GST-fusion pro-
eins were incubated with 5 ml of in vitro translated NS5A
r NS5B for 2 h at 4°C in binding buffer (40 mM HEPES,
H 7.5, 100 mM KCl, 0.1% Nonidet-P40, 20 mM 2-mercap- soethanol). After being washed four times in wash buffer
40 mM HEPES, pH 7.5, 100 mM KCl, 0.4% Nonidet-P40,
0 mM 2-mercaptoethanol), the beads were boiled in
aemmli’s sample buffer for 3 min. The dissociated pro-
eins were separated by SDS–polyacrylamide gel elec-
rophoresis (SDS–PAGE) and detected by autoradiogra-
hy.
ntibodies
For the production of anti-hVAP-33, rats were immu-
ized with hVAP-33 purified as follows: hVAP-33 was
xpressed as a GST-fusion protein in E. coli BL21 strain
nd purified with glutathione–Sepharose 4B beads.
VAP-33 was then released from the GST moiety by
igestion with thrombin (Novagen). Proteins were sepa-
ated by SDS–PAGE, and the specific band was excised,
lectroeluted, and mixed with Freund’s adjuvant before
njecting into rats. To generate polyclonal antibody
gainst NS5A, nucleotides 6255–7595 of HCV genotype
b were expressed as a GST-fusion protein and purified
s described above. Approximately 100 mg of the fusion
rotein was used to immunize New Zealand White rab-
its. HCV patient serum was used to detect NS5B. FITC-
onjugated antibody against rat immunoglobulin G (IgG)
as purchased from American Qualex (La Mirada, CA).
ITC- or TRITC-conjugated goat anti-rabbit IgG was ob-
ained from Pierce (Rockford, IL).
ransfection, immunoprecipitation, and
mmunoblotting
COS7 cells were transfected using the calcium phos-
hate precipitation method in 60-mm-diameter plates.
wo hours before transfection, cells were infected with
ecombinant vaccinia virus vTF7-3 expressing T7 RNA
olymerase (Fuerst et al., 1986). For coimmunoprecipita-
ion study, 5 mg of each plasmid DNA was transfected
nto COS7 cells. After 12 h of incubation at 37°C under
% CO2, the cells were harvested and washed with cold
hosphate-buffered saline. The samples were then col-
ected in 150 ml of Buffer A (10 mM HEPES–KOH, pH 7.8,
0 mM KCl, 1.5 mM MgCl2, 20% glycerol, 0.5 mM DTT).
fter the cells were passed through a 25-gauge needle
ive times, the cell lysates were centrifuged at maximum
peed for 5 min at 4°C. The supernatant was collected
s the cytoplasmic fraction. The pellet was resuspended
n 120 ml of ice-cold Buffer C (20 mM HEPES–KOH, pH
.8, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 25%
lycerol, 0.5 mM DTT) and incubated on ice for 20 min.
he nuclear debris was pelleted by centrifugation at 4°C
or 5 min, and the supernatant was collected as the
uclear fraction. Coimmunoprecipitation was performed
t 4°C in 13 TM10 buffer (50 mM Tris–HCl, pH 7.9, 100
M KCl, 12.5 mM MgCl2, 1 mM EDTA, 10% glycerol, 1
M DTT, 1 mM phenylmethylsulfonyl fluoride). Cell ly-ates (50 ml) were incubated with 3 ml of Sepharose 4B
b
R
b
f
t
o
t
l
m
I
t
s
a
w
m
t
w
w
c
t
a
g
Z
e
a
d
s
t
(
y
S
c
a
a
H
p
o
t
S
5
g
s
t
f
i
p
z
i
1
c
g
o
G
l
a
b
w
N
e
b
p
r
a
s
d
W
t
H
f
u
n
a
p
A
A
A
A
B
B
B
B
B
39INTERACTION OF HCV NS5A AND NS5B WITH A SNARE-LIKE PROTEINeads crosslinked with anti-Flag (Eastman Kodak Co.,
ochester, NY) in a total volume of 200 ml of reaction
uffer. After overnight incubation, beads were washed
our times with 13 TM10 buffer. The precipitates were
hen boiled for 5 min in Laemmli’s sample buffer and run
n a 10% polyacrylamide gel. Proteins were transferred
o a nitrocellulose membrane (Hybond-ECL) and ana-
yzed by enhanced chemiluminescence detection
ethod (Amersham).
mmunofluorescent staining
Cells were plated on 8-well chamber slides and co-
ransfected with pcDNA3- or pcDNA3.1-derived con-
tructs. After being fixed in 4% formaldehyde for 20 min
nd permeabilization in cold acetone for 5 min, cells
ere incubated in 5% bovine serum albumin (BSA) for 20
in to inhibit nonspecific antibody binding. Primary an-
ibodies were diluted in 5% BSA (1:100) and incubated
ith cells for 1 h at room temperature. After three
ashes in PBS, the cells were incubated with fluoro-
hrome-conjugated secondary antibodies for 1 h at room
emperature. Cells were then washed three times in PBS
nd mounted in Vectashield (Vector Laboratories, Burlin-
ame, CA). Confocal microscopy was performed on a
eiss 210 Laser Scanning Confocal Microscope
quipped with an argon and a HeNe laser and appropri-
te filters. Image analysis was performed using the stan-
ard system operating software provided with the micro-
cope. Fluorescence images were superimposed digi-
ally to allow fine comparison. Colocalization of green
FITC) and red (TRITC) signals in a single pixel produces
ellow while separated signals remain green or red.
ubcellular fractionation analysis
Female rabbit lacrimal gland acinar cells or HepG2
ells were subjected to two-dimensional fractionation
nalysis according to the method developed by Mircheff
nd co-workers (see Gierow et al., 1996; Mircheff, 1996;
amm-Alvarez et al., 1997). In brief, cell lysates were
repared from primary cultures of rabbit lacrimal glands
r HepG2 cell cultures and subjected to isopycnic cen-
rifugation on 26.5–80% sorbitol density gradients on a
W-28 rotor (Beckman, Fullerton, CA) at 48,000 rpm for
h (Gierow et al., 1996; Hamm-Alvarez et al., 1997). Each
radient was collected into 13 membrane fractions,
ome of which were combined, yielding 6 samples (frac-
ions 1–2, 3–6, 7–8, 9–10, 11–12, 13). Each sample was
urther separated into 13 fractions by phase partitioning
n a thin-layer countercurrent distribution apparatus at
H 7.0–6.6 shift or pH 7.6 (Mircheff, 1996). Specific en-
yme markers were used to determine the nature of
ntracellular membranes in each fraction (Gierow et al.,
996; Hamm-Alvarez et al., 1997). The ER marker, a-glu-
osidase, was determined with 4-methylumbelliferyl-a-D-
lucoside as substrate (Peters et al., 1972). b-Hex- Bsaminidase, which is predominantly localized on the
olgi and prelysosomes, was determined with 4-methy-
umbelliferyl-a-D-glucosaminide as substrate (Barrett
nd Heath, 1977). The endosome and basal-lateral mem-
rane markers, Na,K-ATPase and acid phosphatase,
ere assayed as described previously (Mircheff, 1989).
a,K-ATPase is primarily associated with the constitutive
ndosomal system and, to a lesser extent, with the
asal-lateral membranes. The distribution of acid phos-
hatase is generally similar to that of Na,K-ATPase, but
elatively more of the acid phosphatase appeared to be
ssociated with the basal-lateral membranes and the
timulation-dependent endosomal compartments. The
istribution of the VAP-33 protein was determined by
estern blotting with the rat polyclonal anti-hVAP-33.
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